
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics
Ariana Rostami, Meghan Lambie, Caberry W. Yu, et al.
Cell Reports (2020) Vol. 31, Iss. 13, pp. 107830-107830
Open Access | Times Cited: 152
Ariana Rostami, Meghan Lambie, Caberry W. Yu, et al.
Cell Reports (2020) Vol. 31, Iss. 13, pp. 107830-107830
Open Access | Times Cited: 152
Showing 1-25 of 152 citing articles:
Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies
Y. M. Dennis Lo, Diana Han, Peiyong Jiang, et al.
Science (2021) Vol. 372, Iss. 6538
Closed Access | Times Cited: 450
Y. M. Dennis Lo, Diana Han, Peiyong Jiang, et al.
Science (2021) Vol. 372, Iss. 6538
Closed Access | Times Cited: 450
A guide to assessing cellular senescencein vitroandin vivo
Estela González‐Gualda, Andrew Baker, Ljiljana Fruk, et al.
FEBS Journal (2020) Vol. 288, Iss. 1, pp. 56-80
Open Access | Times Cited: 430
Estela González‐Gualda, Andrew Baker, Ljiljana Fruk, et al.
FEBS Journal (2020) Vol. 288, Iss. 1, pp. 56-80
Open Access | Times Cited: 430
Release mechanisms of major DAMPs
Atsushi Murao, Monowar Aziz, Haichao Wang, et al.
APOPTOSIS (2021) Vol. 26, Iss. 3-4, pp. 152-162
Open Access | Times Cited: 382
Atsushi Murao, Monowar Aziz, Haichao Wang, et al.
APOPTOSIS (2021) Vol. 26, Iss. 3-4, pp. 152-162
Open Access | Times Cited: 382
Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease
Everett J. Moding, Barzin Y. Nabet, Ash A. Alizadeh, et al.
Cancer Discovery (2021) Vol. 11, Iss. 12, pp. 2968-2986
Open Access | Times Cited: 200
Everett J. Moding, Barzin Y. Nabet, Ash A. Alizadeh, et al.
Cancer Discovery (2021) Vol. 11, Iss. 12, pp. 2968-2986
Open Access | Times Cited: 200
Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms
Stefan Grabuschnig, Abel J. Bronkhorst, Stefan Holdenrieder, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8062-8062
Open Access | Times Cited: 161
Stefan Grabuschnig, Abel J. Bronkhorst, Stefan Holdenrieder, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8062-8062
Open Access | Times Cited: 161
Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine
Mohammadreza Kasravi, Armin Ahmadi, Amirhesam Babajani, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 142
Mohammadreza Kasravi, Armin Ahmadi, Amirhesam Babajani, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 142
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance
Pavel Stejskal, Hani Goodarzi, Josef Srovnal, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 132
Pavel Stejskal, Hani Goodarzi, Josef Srovnal, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 132
Stress and circulating cell-free mitochondrial DNA: A systematic review of human studies, physiological considerations, and technical recommendations
Caroline Trumpff, Jeremy Michelson, Claúdia Jacques Lagranha, et al.
Mitochondrion (2021) Vol. 59, pp. 225-245
Open Access | Times Cited: 129
Caroline Trumpff, Jeremy Michelson, Claúdia Jacques Lagranha, et al.
Mitochondrion (2021) Vol. 59, pp. 225-245
Open Access | Times Cited: 129
Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges
Enrique Sanz‐García, Eric Y. Stutheit-Zhao, Scott V. Bratman, et al.
Science Advances (2022) Vol. 8, Iss. 4
Open Access | Times Cited: 114
Enrique Sanz‐García, Eric Y. Stutheit-Zhao, Scott V. Bratman, et al.
Science Advances (2022) Vol. 8, Iss. 4
Open Access | Times Cited: 114
Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis
Estela Sánchez‐Herrero, Roberto Serna‐Blasco, Lucía Robado de Lope, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 71
Estela Sánchez‐Herrero, Roberto Serna‐Blasco, Lucía Robado de Lope, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 71
Bridging biological cfDNA features and machine learning approaches
Tina Moser, Stefan Kühberger, Isaac Lazzeri, et al.
Trends in Genetics (2023) Vol. 39, Iss. 4, pp. 285-307
Open Access | Times Cited: 67
Tina Moser, Stefan Kühberger, Isaac Lazzeri, et al.
Trends in Genetics (2023) Vol. 39, Iss. 4, pp. 285-307
Open Access | Times Cited: 67
Circulating DNA fragmentomics and cancer screening
Alain R. Thierry
Cell Genomics (2023) Vol. 3, Iss. 1, pp. 100242-100242
Open Access | Times Cited: 66
Alain R. Thierry
Cell Genomics (2023) Vol. 3, Iss. 1, pp. 100242-100242
Open Access | Times Cited: 66
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 40
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 40
Cellular senescence in cancer: from mechanisms to detection
Hui‐Ling Ou, Reuben Hoffmann, Cristina González‐López, et al.
Molecular Oncology (2020) Vol. 15, Iss. 10, pp. 2634-2671
Open Access | Times Cited: 132
Hui‐Ling Ou, Reuben Hoffmann, Cristina González‐López, et al.
Molecular Oncology (2020) Vol. 15, Iss. 10, pp. 2634-2671
Open Access | Times Cited: 132
Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma
Yue Cao, Catherine T. Haring, Collin Brummel, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 2, pp. 350-359
Open Access | Times Cited: 79
Yue Cao, Catherine T. Haring, Collin Brummel, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 2, pp. 350-359
Open Access | Times Cited: 79
Cellular senescence in cancer: clinical detection and prognostic implications
Andreas Domen, Christophe Deben, Jasper Verswyvel, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 57
Andreas Domen, Christophe Deben, Jasper Verswyvel, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 57
Endothelial Senescence: A New Age in Pulmonary Hypertension
Miranda K. Culley, Stephen Y. Chan
Circulation Research (2022) Vol. 130, Iss. 6, pp. 928-941
Open Access | Times Cited: 39
Miranda K. Culley, Stephen Y. Chan
Circulation Research (2022) Vol. 130, Iss. 6, pp. 928-941
Open Access | Times Cited: 39
Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA
Nicholas P. Semenkovich, Jeffrey J. Szymanski, Noah Earland, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006284-e006284
Open Access | Times Cited: 34
Nicholas P. Semenkovich, Jeffrey J. Szymanski, Noah Earland, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006284-e006284
Open Access | Times Cited: 34
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types
Pashtoon Murtaza Kasi, Jessica Lee, Lincoln W. Pasquina, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 4, pp. 836-848
Open Access | Times Cited: 25
Pashtoon Murtaza Kasi, Jessica Lee, Lincoln W. Pasquina, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 4, pp. 836-848
Open Access | Times Cited: 25
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
Klaus Pantel, Catherine Alix‐Panabières
Nature Reviews Clinical Oncology (2024) Vol. 22, Iss. 1, pp. 65-77
Closed Access | Times Cited: 10
Klaus Pantel, Catherine Alix‐Panabières
Nature Reviews Clinical Oncology (2024) Vol. 22, Iss. 1, pp. 65-77
Closed Access | Times Cited: 10
The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-small cell lung cancer
Gaia Passarella, Stefania Canova, Maria Ida Abbate, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Gaia Passarella, Stefania Canova, Maria Ida Abbate, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Targeting NINJ1-mediated cell rupture to treat inflammatory diseases
Claire Ju-Eun Hur, Benjamin E. Steinberg
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Claire Ju-Eun Hur, Benjamin E. Steinberg
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Refined characterization of circulating tumor DNA through biological feature integration
Havell Markus, Dineika Chandrananda, Elizabeth Moore, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Havell Markus, Dineika Chandrananda, Elizabeth Moore, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
EV‐ADD, a database for EV‐associated DNA in human liquid biopsy samples
Thupten Tsering, Mingyang Li, Yunxi Chen, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 10
Open Access | Times Cited: 31
Thupten Tsering, Mingyang Li, Yunxi Chen, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 10
Open Access | Times Cited: 31
Association of neutrophil extracellular traps with the production of circulating DNA in patients with colorectal cancer
Brice Pastor, Jean-Daniel Abraham, Ekaterina Pisareva, et al.
iScience (2022) Vol. 25, Iss. 2, pp. 103826-103826
Open Access | Times Cited: 29
Brice Pastor, Jean-Daniel Abraham, Ekaterina Pisareva, et al.
iScience (2022) Vol. 25, Iss. 2, pp. 103826-103826
Open Access | Times Cited: 29